Comparing the Imperfect With the Imperfect: The Imprecise Science of Assessing the Risk and Benefits of Anticoagulation in Atrial Fibrillation

Circulation - United States
doi 10.1161/circulationaha.114.009979
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2012English

Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

The Science of Monetary Policy: An Imperfect Knowledge Perspective

SSRN Electronic Journal
2016English

Uncompleted Construction of the Imperfect

Siberian Historical Research
AnthropologyArcheologyHistory
2017English

Corticosteroids and the Risk of Atrial Fibrillation

Archives of Internal Medicine
2006English

Pcv108 - Prescribing Choice and the Cost of Anticoagulation in Atrial Fibrillation: A Real World Study Comparing Healthcare Expenditure With Warfarin and Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients With ESRD: Con

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2016English

Measuring Research Benefits in an Imperfect Market

Agricultural Economics
AgronomyEconomicsCrop ScienceEconometrics
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy